A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia
Status:
Terminated
Trial end date:
2018-09-28
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the efficacy of the study drug known as
lanabecestat in participants with mild Alzheimer's disease (AD) dementia.